BB Biotech AG Financials

Market Capitalization CHF1.94 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.46
Forward PE	9.08
Price to Sales TTM	CHF-9.73
Price to Book MRQ	CHF
Enterprise to Revenue	0.00
Enterprise to EBITDA

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	%
Operating Margin	%
Return on Assets TTM	%
Return on Equity TTM	-8.89%

Income Statement

Revenue TTM	CHF-199,567,000
Revenue per Share TTM	CHF-3.64
Quarterly Revenue Growth	88.68%
Gross Profit TTM	CHF0
EBITDA	CHF0
Net Income to Common TTM	CHF-206,607,000
Diluted EPS TTM	CHF-3.77
Quarterly Earnings Growth YoY	267.74%

Balance Sheet

Total Cash MRQ	CHF0
Total Cash per Share MRQ	CHF
Total Debt MRQ	CHF
Total Debt to Equity MRQ	0.00
Current Ratio MRQ
Book Value per Share MRQ	CHF40.70

Cash Flow

Operating Cash Flow TTM	CHFNone
Levered Free Cash Flow TTM	CHF-206,607,000

BION Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	54,826,000
Float Shares	None
Avg 10 Volume	108,255
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	%
% Held by Institutions	%

Stock Price Summary

Beta
Fifty Two Week Low	CHF34.50
Fifty Two Week High	CHF49.80
Fifty Two Week Change	-14.53%
Day 50 MA	CHF37.14
Day 200 MA	CHF39.77

Dividends and Splits

Forward Annual Dividend Rate	CHF8.00
Forward Annual Dividend Yield	20.75%
Trailing Annual Dividend Rate	CHF2.00
Trailing Annual Dividend Yield	5.19%
Payout Ratio	%
Dividend Date	2024-03-27
Ex Dividend Date	2024-03-25
Last Split Factor
Last Split Date	2016-03-29